Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MTS-01 for Radiotherapy-Induced Alopecia
NCT00713154Phase 2Terminated
- Sponsor
- Mitos Pharmaceuticals, Inc.
- Start
- Apr 2007
- Primary completion
- Sep 2007
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of tempol in alopecia, sponsored by Mitos Pharmaceuticals, Inc.. Started Apr 2007; status: terminated.
02
Drugs
tempol
03
Conditions
alopecia
Beyond the preview
Go deeper on NCT00713154.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00713154.